NCT02352402View on ClinicalTrials.gov

The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery

PHASE3UnknownINTERVENTIONAL
Enrollment

487

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Coronary Artery DiseaseStable AnginaAcute Coronary Syndrome
Interventions
DRUG

Ticagrelor

DRUG

Placebo

Trial Locations (6)

3435CM

St Antonius Hospital, Nieuwegein

5623 EJ

Catharina Ziekenhuis, Eindhoven

Unknown

Medisch Spectrum Twente, Enschede

Universitair Medisch Centrum Groningen, Groningen

Radboud UMC, Nijmegen

Erasmus Erasmus UMC, Rotterdam

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

J.M. ten Berg

OTHER